Magali Lacroix-Triki

Title: Magali Lacroix-Triki: Innovator in Breast Cancer Prognosis

Introduction

Magali Lacroix-Triki is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical technology, particularly in breast cancer prognosis. Her innovative work focuses on utilizing machine learning to enhance predictive capabilities in cancer treatment.

Latest Patents

Magali holds a patent for "Systems and methods for determining breast cancer prognosis and associated features." This patent describes a computer-implemented method and a machine learning model designed to predict the likelihood of relapse in breast cancer patients following treatment. It also includes the ability to predict tumors within whole slide images and assess biomarker status in breast cancer tissue.

Career Highlights

Throughout her career, Magali has worked with notable companies, including Owkin France SAS and Owkin, Inc. Her expertise in machine learning and medical applications has positioned her as a key figure in the development of advanced diagnostic tools.

Collaborations

Magali has collaborated with talented professionals in her field, including Charlie Saillard and Benoit Schmauch. These partnerships have furthered her research and innovation in breast cancer prognosis.

Conclusion

Magali Lacroix-Triki's contributions to breast cancer prognosis through her innovative patent and collaborations highlight her role as a leading inventor in medical technology. Her work continues to pave the way for advancements in cancer treatment and patient care.